Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Immunology

• Publication date

  2016-02-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1501783PMID 26873994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2‐deoxy‐glucose affects effector functions

  2015cited by this paper
• The metabolic checkpoint kinase mTOR is essential for interleukin-15 signaling during NK cell development and activation

  2014cited by this paper
• The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.

  2014cited by this paper
• Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens

  2014cited by this paper
• mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function

  2014cited by this paper
• Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch

  2013cited by this paper
• Posttranscriptional control of T cell effector function by aerobic glycolysis.

  2013influential reference
• Metabolic pathways in immune cell activation and quiescence.

  2013cited by this paper
• Location and cellular stages of natural killer cell development.

  2013cited by this paper
• Fueling Immunity: Insights into Metabolism and Lymphocyte Function

  2013cited by this paper
• PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells

  2012cited by this paper
• Metabolic reprogramming and metabolic dependency in T cells

  2012cited by this paper
• The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

  2011cited by this paper
• Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus

  2011cited by this paper
• Changes in Cytokine Levels and NK Cell Activation Associated with Influenza

  2011cited by this paper
• Longevity and Composition of Cellular Immune Responses Following Experimental Plasmodium falciparum Malaria Infection in Humans

  2011cited by this paper
• NK Cells as Effectors of Acquired Immune Responses: Effector CD4+ T Cell-Dependent Activation of NK Cells Following Vaccination

  2010cited by this paper
• Direct Binding of Human NK Cell Natural Cytotoxicity Receptor NKp44 to the Surfaces of Mycobacteria and Other Bacteria

  2008cited by this paper
• Human natural killer cells.

  2008cited by this paper
• Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage

  2007cited by this paper
• CD56bright Human NK Cells Differentiate into CD56dim Cells: Role of Contact with Peripheral Fibroblasts

  2007cited by this paper
• CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation1

  2007cited by this paper
• Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth.

  2006cited by this paper
• Glucose transporter 1 expression identifies a population of cycling CD4+ CD8+ human thymocytes with high CXCR4-induced chemotaxis.

  2005cited by this paper
• Of Mice and Not Men: Differences between Mouse and Human Immunology

  2004cited by this paper
• CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

  2003cited by this paper
• KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.

  2002cited by this paper
• Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

  2001cited by this paper
• Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

  2001cited by this paper
• The biology of human natural killer-cell subsets.

  2001cited by this paper
• Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody.

  1998cited by this paper
• Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo

  1990cited by this paper
• Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

  1990cited by this paper
• Comparative studies of human FcRIII-positive and negative natural killer cells.

  1989cited by this paper
• The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.

  1986cited by this paper
• Human natural killer cells.

  1979cited by this paper

• Dynamics of natural killer cell function upon recurrent stimulation.

  2026cites this paper
• From innate immunity to precision cancer therapy: the clinical advancement of NK cell therapy.

  2026cites this paper
• Glutathione is critical for NK cell-mediated immunity.

  2026cites this paper
• NK cell adaptation in the tumor microenvironment: Insights for NK cell-based immunotherapy.

  2025cites this paper
• Cyclic GMP-AMP Synthase (cGAS) Deletion Promotes Less Prominent Inflammatory Macrophages and Sepsis Severity in Catheter-Induced Infection and LPS Injection Models

  2025cites this paper
• Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy

  2025cites this paper
• The role of immune cells glycolysis in neuroinflammation secondary to intracerebral hemorrhage.

  2025cites this paper
• Bidirectional regulation of lipid metabolism and the tumor microenvironment: new perspectives from mechanism to therapy

  2025cites this paper
• The art of war: burning stores to fuel anti-viral immunity

  2025cites this paper
• The inhibitory receptor LAG3 affects NK cell IFN-γ production through glycolysis and the PSAT1/STAT1/IFNG pathway

  2025cites this paper
• Chronic HBV infection impairs the glucose metabolism and effector function of NK cells via HBsAg/IL-15/mTOR axis

  2025cites this paper
• Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications

  2025cites this paper
• Mitochondrial dynamics and metabolic attributes regulate function of natural killer cell and infiltration in tumor microenvironment modulating disease progression.

  2025cites this paper
• Altered mitochondrial mass and fatty acid uptake by natural killer cells in HIV-exposed uninfected children at 6 years of age

  2025cites this paper
• Research status of colorectal cancer treatment based on natural killer cell immunotherapy

  2025cites this paper
• Glutaminase activity maintains NK cell cytotoxicity through metabolic regulation of effector function

  2025cites this paper
• Glucose Metabolism Reprogramming of Immune Cells in the Microenvironment of Pancreatic and Hepatobiliary Cancers

  2025cites this paper
• Impaired natural killer cell migration in HIV-infected individuals is caused by TIGIT-mediated inhibition of HIF-1α-dependent glycolysis

  2025cites this paper
• Natural killer cells: the immune frontline against circulating tumor cells

  2025cites this paper
• Pivotal role of exogenous pyruvate in human natural killer cell metabolism

  2025influential citation
• Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy

  2025cites this paper
• Differentiation-associated ISG expression of NK cells in chronic viral infection

  2025cites this paper
• Leptin, NK cells, and the weight of immunity: Insights into obesity.

  2025cites this paper
• Lactate Metabolic Reprogramming Mediated by CircRNA–LDHA Complex Facilitates Innate Immune Evasion of Liver Cancer

  2025cites this paper
• Genetic manipulation of OGT enhances NK cell-mediated cytotoxicity in tumor immunity.

  2025cites this paper
• Autofluorescence lifetime imaging classifies human B and NK cell activation state

  2025cites this paper
• The metabolic drivers of IFN-γ release: glycolysis and acetyl CoA ride in the front seat.

  2025cites this paper
• A prognostic risk prediction model for gastric cancer based on the EFNA4 and ETS1 regulatory axis in tumor cells

  2025cites this paper
• Mitochondria in the immune system: Therapeutic potential from mitochondria transfer

  2025influential citation
• Species-specific serine metabolism differentially controls natural killer cell functions

  2025influential citation
• Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer.

  2025cites this paper
• CD56 does not contribute to the anti-tumor, tissue homing, and glycolytic capacity of human NK cells.

  2024cites this paper
• Expression of Molecules Characterizing Metabolic and Cytotoxic Activity of Natural Killer Different Subpopulations of Peripheral Blood During Pregnancy

  2024cites this paper
• Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments

  2024cites this paper
• Human tissue-resident NK cells in the lung have a higher glycolytic capacity than non-tissue-resident NK cells in the lung and blood

  2024cites this paper
• Tumor-treating fields increase cytotoxic degranulation of natural killer cells against cancer cells

  2024cites this paper
• The Role of Natural Killer Cells and Their Metabolism in HIV-1 Infection

  2024influential citation
• Emerging Technologies for the Assessment of Natural Killer Cell Activity

  2024cites this paper
• Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity.

  2024cites this paper
• A “Prime and Expand” strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapy

  2024cites this paper
• Research Progress of Warburg Effect in Hepatocellular Carcinoma.

  2024cites this paper
• HLA-DR Expression in Natural Killer Cells Marks Distinct Functional States, Depending on Cell Differentiation Stage

  2024cites this paper
• Expression of Molecules Characterizing Metabolic and Cytotoxic Activity of Different Natural Killer Cell Subpopulations in Peripheral Blood during Pregnancy

  2024cites this paper
• Cancer immunometabolism: advent, challenges, and perspective

  2024cites this paper
• Nutrient transporter pattern in CD56dim NK cells: CD16 (FcγRIIIA)-dependent modulation and association with memory NK cell functional profile

  2024cites this paper
• Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy

  2024influential citation
• Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy.

  2024cites this paper
• Iron deficiency in people with obesity drives defective Natural Killer cell mitochondrial fitness and function

  2024cites this paper
• Optimizing glutamine concentration enhances ex vivo expansion of natural killer cells through improved redox status

  2024cites this paper
• NK cells as powerful therapeutic tool in cancer immunotherapy

  2024cites this paper
• Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma.

  2024cites this paper
• Restriction of Glycolysis Increases Serial Killing Capacity of Natural Killer Cells

  2024cites this paper
• Induced CD8α identifies human NK cells with enhanced proliferative fitness and modulates NK cell activation

  2024cites this paper
• Dynamic immune status analysis of peripheral blood mononuclear cells in patients with Klebsiella pneumoniae bloodstream infection sepsis using single-cell RNA sequencing

  2024cites this paper
• Fatty acid oxidation fuels natural killer cell responses against infection and cancer

  2024cites this paper
• Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy

  2024cites this paper
• Expansion and characterization of immune suppressive CD56(bright)Perforin(-) regulatory-like natural killer cells in chronic graft-versus-host disease.

  2024cites this paper
• Glycolytic metabolism: Food for immune cells, fuel for depression?

  2024cites this paper
• Immunometabolism in head and neck squamous cell carcinoma: Hope and challenge.

  2024cites this paper
• Tumor microenvironment induced switch to mitochondrial metabolism promotes suppressive functions in immune cells.

  2024cites this paper
• Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment

  2024cites this paper
• Real-time ex vivo monitoring of NK cell migration toward obesity-associated oesophageal adenocarcinoma following modulation of CX3CR1

  2024cites this paper
• Single-cell view and a novel protective macrophage subset in perivascular adipose tissue in T2DM

  2024cites this paper
• Cell‐Type‐Specific Autophagy in Human Leukocytes

  2024cites this paper
• Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives

  2024cites this paper
• PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival

  2024cites this paper
• Unraveling the H19/GAS1 axis in recurrent implantation failure: A potential biomarker for diagnosis and insight into immune microenvironment alteration

  2024cites this paper
• Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer

  2024cites this paper
• IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity

  2024cites this paper
• MEF2C regulates NK cell effector functions through control of lipid metabolism

  2024cites this paper
• Glycolysis inhibition affects proliferation and cytotoxicity of Vγ9Vδ2 T cells expanded for adoptive cell therapy.

  2024cites this paper
• Molecular Targets for Cannabinoids in Natural Killer Cells: Do They Modulate the Antitumor Activity?

  2024cites this paper
• PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer

  2023cites this paper
• Regulation of short-chain fatty acids in the immune system

  2023cites this paper
• Sterol regulatory element binding transcription factor 1 promotes proliferation and migration in head and neck squamous cell carcinoma

  2023cites this paper
• Enhancement of the Anticancer Ability of Natural Killer Cells through Allogeneic Mitochondrial Transfer

  2023cites this paper
• The application of autologous cancer immunotherapies in the age of memory-NK cells

  2023cites this paper
• Elevated exosome-transferrable lncRNA EPB41L4A-AS1 in CD56bright NK cells is responsible for the impaired NK function in neuroblastoma patients by suppressing cell glycolysis.

  2023cites this paper
• Glucagon‐like peptide‐1 therapy in people with obesity restores natural killer cell metabolism and effector function

  2023cites this paper
• Autofluorescence lifetime imaging classifies human lymphocyte activation and subtype

  2023cites this paper
• Butyrate limits human natural killer cell effector function

  2023cites this paper
• Altered Fatty Acid Oxidation in Lymphocyte Populations of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  2023cites this paper
• Natural killer cells and type 1 innate lymphoid cells in cancer.

  2023cites this paper
• Metabolism of NK cells during viral infections

  2023cites this paper
• Metabolic regulation of NK cell antiviral functions during cytomegalovirus infection.

  2023cites this paper
• Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies

  2023cites this paper
• Unique metabolism and protein expression signature in human decidual NK cells

  2023cites this paper
• Cytokine-Induced Memory-Like NK Cells: Emerging strategy for AML immunotherapy.

  2023cites this paper
• NK cell exhaustion in the tumor microenvironment

  2023cites this paper
• Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells

  2023cites this paper
• Enterohepatocentrism as the basis of human psychosomatic pathology

  2023cites this paper
• Mitochondrial Damage-Associated Molecular Patterns and Metabolism in the Regulation of Innate Immunity

  2023cites this paper
• Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy

  2023cites this paper
• Metabolic regulation of NK cell function: implications for immunotherapy

  2023cites this paper
• Repeated social defeat stress leads to immunometabolic shifts in innate immune cells of the spleen

  2023cites this paper
• NK cells vs. obesity: A tale of dysfunction & redemption.

  2023cites this paper
• Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

  2023cites this paper
• Cross-talk between insulin resistance and nitrogen species in hypoxia leads to deterioration of tissue and homeostasis.

  2023cites this paper
• Intrinsic and extrinsic factors determining natural killer cell fate: Phenotype and function.

  2023cites this paper
• Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities.

  2023cites this paper